Abstract
Reactive oxygen species (ROS) have been implicated in a variety of age-related diseases, including multiple cardiovascular disorders. However, translation of ROS scavengers (antioxidants) into The clinic has not been successful. These antioxidants grossly reduce total levels of cellular ROS including ROS that participate in physiological signaling. In this review, we challenge The traditional antioxidant therapeutic approach that targets ROS directly with novel approaches that improve mitochondrial functions to more effectively treat cardiovascular diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 1783-1799 |
| Number of pages | 17 |
| Journal | Circulation Research |
| Volume | 116 |
| Issue number | 11 |
| DOIs | |
| State | Published - 22 May 2015 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- mitochondria
- mitochondrial degradation
- mitochondrial dynamics
- protein kinase C
- reactive oxygen species
All Science Journal Classification (ASJC) codes
- Physiology
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Mitochondrial reactive oxygen species at The heart of The matter: New therapeutic approaches for cardiovascular diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver